We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+8.93%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$14.4B
AUM Growth
-$406M
Cap. Flow
-$163M
Cap. Flow %
-1.13%
Top 10 Hldgs %
24.27%
Holding
957
New
98
Increased
341
Reduced
353
Closed
82

Top Buys

Rank Stock Value
1
BZ icon
Kanzhun
BZ
+$45.9M
2
STKL
SunOpta
STKL
+$45M
3
ZTO icon
ZTO Express
ZTO
+$44.4M
4
JPM icon
JPMorgan Chase
JPM
+$39.9M
5
XIFR
XPLR Infrastructure LP
XIFR
+$36.1M

Top Sells

Rank Stock Value
1
MELI icon
Mercado Libre
MELI
+$79.9M
2
MSFT icon
Microsoft
MSFT
+$58.5M
3
VERU icon
Veru
VERU
+$53.9M
4
PG icon
Procter & Gamble
PG
+$50.5M
5
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$37M

Sector Composition

Rank Sector Weight
1 Healthcare 30.95%
2 Technology 26.5%
3 Financials 9.1%
4 Consumer Discretionary 8.02%
5 Industrials 7.34%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CNP icon
851
CenterPoint Energy
CNP
$28.3B
-53,360
Closed -$1.6M
CP icon
852
Canadian Pacific Kansas City
CP
$81B
-35,831
Closed -$2.67M
CSX icon
853
CSX Corp
CSX
$94B
-853,121
Closed -$26.4M
D icon
854
Dominion Energy
D
$62.1B
-52,664
Closed -$3.23M
DBX icon
855
Dropbox
DBX
$7.78B
-18,670
Closed -$418K
DEO icon
856
Diageo
DEO
$49.6B
-7,866
Closed -$1.4M
EXPE icon
857
Expedia Group
EXPE
$36.5B
-5,487
Closed -$481K
FATE icon
858
Fate Therapeutics
FATE
$275M
-460,436
Closed -$4.65M
FTS icon
859
Fortis
FTS
$29.3B
-12,449
Closed -$498K
GFI icon
860
Gold Fields
GFI
$28.8B
-18,600
Closed -$193K
GOCO
861
DELISTED
GoHealth
GOCO
-10,806
Closed -$113K
ITRI icon
862
Itron
ITRI
$4.48B
-78,181
Closed -$3.96M
ITUB icon
863
Itaú Unibanco
ITUB
$89.8B
-123,642
Closed -$514K
JBGS
864
JBG SMITH
JBGS
$846M
-105,000
Closed -$1.99M
KIM icon
865
Kimco Realty
KIM
$17.5B
-41,712
Closed -$883K
L icon
866
Loews
L
$24.5B
-28,568
Closed -$1.67M
LEVI icon
867
Levi Strauss
LEVI
$9.49B
-167,543
Closed -$2.6M
LGND icon
868
Ligand Pharmaceuticals
LGND
$5.77B
-13,546
Closed -$905K
LPX icon
869
Louisiana-Pacific
LPX
$5.14B
-40,000
Closed -$2.37M
MAT icon
870
Mattel
MAT
$4.47B
-29,028
Closed -$518K
MLAB icon
871
Mesa Laboratories
MLAB
$551M
-5,150
Closed -$856K
MYGN icon
872
Myriad Genetics
MYGN
$476M
-45,398
Closed -$659K
NKTR icon
873
Nektar Therapeutics
NKTR
$2.39B
-39,729
Closed -$1.35M
NSC icon
874
Norfolk Southern
NSC
$75.4B
-92,549
Closed -$22.8M
NTES icon
875
NetEase
NTES
$83B
-7,600
Closed -$552K

Similar funds

Candriam SCA's Q1 2023 Portfolio in Review

As of Q1 2023, Candriam SCA held 957 positions worth $14.4B, down 2.7% from $14.8B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Candriam SCA's Q1 2023 filing shows 98 new, 341 increased, 353 reduced and 82 closed positions. Its largest new stake was Kanzhun: 2,106,130 shares worth $36.9M. The largest sale was Mercado Libre, an estimated $79.9M.

By sector, the portfolio is most concentrated in Healthcare at 31% of assets, down from 33% a quarter earlier, followed by Technology and Financials.

  • Candriam SCA's largest Q1 2023 buy was Kanzhun: 2,106,130 shares worth $36.9M.
  • Candriam SCA added most to SunOpta in Q1 2023, an estimated $45M increase.
  • Candriam SCA's biggest Q1 2023 reduction was Mercado Libre, cutting an estimated $79.9M.
  • Candriam SCA fully exited Veru in Q1 2023, selling an estimated $53.9M.
  • Candriam SCA's ten largest holdings make up 24% of its $14.4B portfolio in Q1 2023.
  • Candriam SCA opened 98 new positions and closed 82 in Q1 2023.
  • Candriam SCA's portfolio value fell 2.7% quarter-over-quarter to $14.4B.

Based on Candriam SCA's 13F filing for Q1 2023, filed 12 May 2023.